Table 2 Caffeine therapy of neonates in OOP and non-OOP groups
 Variables | High ALP group (N = 52) | Low ALP group (N = 216) | p-value |
|---|---|---|---|
Duration of therapy of caffeine (days) ## | 28.0 ± 0.0 | 27.7 ± 0.8 | 0.008 |
Cumulative dose of caffeine (mg) @ | 110.2 (96.0–125.0) | 74.8 (70.0–80.0) |  < 0.001 |
Maximum daily dose of caffeine (mg/kg/day) @ | 10.0 (7.5–10.0) | 5.5 (5.0–7.0) |  < 0.001 |